New Pharma Rankings On Global Access To Medicine Released
Judy Stone reports on the 2016 Access to Medicine Index and refers to some of the main findings, namely those related to R&D, Pricing and Governance & Compliance.
A newly released report by the Access to Medicine Foundation examines how pharmaceutical companies are dealing with these disparities. This nonprofit research group, based in the Netherlands, is funded by the Bill and Melinda Gates Foundation, the UK Department for International Development and the Dutch Ministry of Foreign Affairs, and by several NGOs; it accepts no funding from pharmaceutical companies. It reports these findings as an index or report card, ranking companies on these parameters: management of access to their medicine; market influence and compliance; research and development; pricing, manufacturing and distribution; patents and licensing; capacity building; and product donation. (…)